Ultralife reported $47.9 million in Revenue , GAAP Earnings Per Share of $0.15 and a Gross Profit of $13.9 million, translating to a 28.9% Margin , while adjusted EBITDA rose to $6.1 million. The numbers surpass prior‑year performance and exceed consensus expectations, indicating stronger profit dynamics and a growing order Backlog that could sustain earnings momentum.
Key Highlights
- Sales of $47.9 million; GAAP EPS $0.15; gross margin 28.9%
- Gross profit $13.9 million; Operating Income $3.4 million
- Adjusted EBITDA $6.1 million; one‑time costs $0.9 million
- Backlog $117.5 million, the highest level recorded to date
Ultralife Corp ( Nasdaq : ULBI) reported second‑quarter revenue of $47.9 million. While revenue was modestly lower than the comparable period a year earlier, gross profit rose to $13.9 million, delivering a gross margin of 28.9% versus the prior‑year level of 23.9%. GAAP earnings per share measured $0.15, an improvement over the $0.05 reported in the previous year, and adjusted EBITDA reached $6.1 million.
EPS Performance Relative to Expectations
Analysts had anticipated earnings per share in the vicinity of the prior year’s level. The company’s ability to post a positive GAAP EPS underscores a shift toward profitability, driven by improved margins and controlled one‑time expenses.
Revenue Mix and Margin Dynamics
Revenue growth was tempered by a decline in Energy Products sales, while the Communications Systems segment contributed a notable upside. After excluding a $1.1 million IEEPA refund, the underlying gross margin settled at 26.6%, reflecting the impact of product‑mix changes and pricing discipline across the portfolio.
Operating Income, One‑Time Costs, and Cash Position
Operating income for the quarter was $3.4 million, supported by one‑time costs of $0.9 million. Adjusted EBITDA expanded to $6.1 million, reinforcing a solid earnings profile without reliance on recurring expense reductions. The company continues to invest in Research and Development to sustain its competitive position in the defense and aerospace sectors.
Backlog Expansion Fuels Future Growth Prospects
Ultralife closed the quarter with a record backlog of $117.5 million, up from $115.1 million at the end of the prior quarter. The expanded order book, driven by new communications solutions and battery programs for defense applications, positions the company for a trajectory of revenue acceleration as the backlog translates into shipments later in the year. Stakeholders will monitor the upcoming third‑quarter results for evidence that the backlog supports continued top‑line growth and margin improvement.
Peers Moving on This News
- ChargePoint Holdings Inc (CHPT) little changed
- NeoVolta Inc (NEOV) down 3.0%
- SunPower Inc (SPWR) down 1.5%
Analysis based on the Form 8-K filed 7 August 2026.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making Investment decisions.






Please wait processing your request...